GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gencurix Inc (XKRX:229000) » Definitions » Common Stock

Gencurix (XKRX:229000) Common Stock : ₩0 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Gencurix Common Stock?

Gencurix's quarterly common stock increased from Sep. 2023 (₩6,659 Mil) to Dec. 2023 (₩6,781 Mil) but then declined from Dec. 2023 (₩6,781 Mil) to Mar. 2024 (₩0 Mil).

Gencurix's annual common stock increased from Dec. 2021 (₩3,279 Mil) to Dec. 2022 (₩3,334 Mil) and increased from Dec. 2022 (₩3,334 Mil) to Dec. 2023 (₩6,781 Mil).


Gencurix Common Stock Historical Data

The historical data trend for Gencurix's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gencurix Common Stock Chart

Gencurix Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 2,696.36 3,199.45 3,279.21 3,334.29 6,780.94

Gencurix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,334.29 6,628.07 6,658.65 6,780.94 -

Gencurix Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Gencurix (XKRX:229000) Business Description

Traded in Other Exchanges
N/A
Address
9th Floor, Hanhwa Bizmetro I, Guro 3-dong, Guro-gu, Seoul, KOR, 152-733
Gencurix Inc develops diagnosis treatment kits. It offers products including GenesWell BCT, a breast cancer test; GenesWell ddEGFR Mutation Test; GenesWell CDx EGFR Mutation Test; and GenesWell ddEGFR mutation Test.

Gencurix (XKRX:229000) Headlines

No Headlines